| Mrs Kimberly Ann Morrison, LCSW LC17144 | |
|
2821 N Belfast Ave, Augusta, ME 04330-0206 | |
| (207) 200-5840 | |
| (855) 508-6515 |
| Full Name | Mrs Kimberly Ann Morrison |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 9 Years |
| Location | 2821 N Belfast Ave, Augusta, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518326735 | NPI | - | NPPES |
| 15877 | Medicaid | ME | |
| MC15877 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | MC15877 (Maine) | Primary |
| Entity Name | Health Affiliates Maine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932413556 PECOS PAC ID: 1951594076 Enrollment ID: O20101021000912 |
News Archive
It's resolution time again. Losing weight, getting fit and volunteering to help others top resolution lists each January(1). Setting a realistic goal and making a commitment to others are great strategies to battle resolution dissolution. Susan G. Komen for the Cure® has a portfolio of fitness events to accommodate both, including the organization's newest event, the Susan G. Komen 3-Day for the Cure(TM).
A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) T-cell therapy.
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.
Researchers from the Johns Hopkins Bloomberg School of Public Health urge wider use of oral rehydration solution (ORS), zinc supplementation and rotavirus vaccine to reduce the deaths from diarrheal disease worldwide.
› Verified 5 days ago
| Entity Name | Seasons Of Life Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316413057 PECOS PAC ID: 7416296207 Enrollment ID: O20190221001626 |
News Archive
It's resolution time again. Losing weight, getting fit and volunteering to help others top resolution lists each January(1). Setting a realistic goal and making a commitment to others are great strategies to battle resolution dissolution. Susan G. Komen for the Cure® has a portfolio of fitness events to accommodate both, including the organization's newest event, the Susan G. Komen 3-Day for the Cure(TM).
A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) T-cell therapy.
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.
Researchers from the Johns Hopkins Bloomberg School of Public Health urge wider use of oral rehydration solution (ORS), zinc supplementation and rotavirus vaccine to reduce the deaths from diarrheal disease worldwide.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kimberly Ann Morrison, LCSW LC17144 2821 N Belfast Ave, Augusta, ME 04330-0206 Ph: (207) 200-5840 | Mrs Kimberly Ann Morrison, LCSW LC17144 2821 N Belfast Ave, Augusta, ME 04330-0206 Ph: (207) 200-5840 |
News Archive
It's resolution time again. Losing weight, getting fit and volunteering to help others top resolution lists each January(1). Setting a realistic goal and making a commitment to others are great strategies to battle resolution dissolution. Susan G. Komen for the Cure® has a portfolio of fitness events to accommodate both, including the organization's newest event, the Susan G. Komen 3-Day for the Cure(TM).
A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) T-cell therapy.
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.
Researchers from the Johns Hopkins Bloomberg School of Public Health urge wider use of oral rehydration solution (ORS), zinc supplementation and rotavirus vaccine to reduce the deaths from diarrheal disease worldwide.
› Verified 5 days ago
Ms. Vickie Jacobs Fisher, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 49 Oak St, Maine Behavioral Health Organization, Augusta, ME 04330 Phone: 207-441-8525 | |
Mr. Gregory J Skillman, LMSW-CC Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 250 Arsenal Street, Augusta, ME 04330 Phone: 207-624-4728 | |
Mr. Edward P Walsh, LMSW-CC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 Va Center Dr, Mhc, Augusta, ME 04239 Phone: 207-500-9321 | |
Ms. Donna Marie Gallant, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 Fax: 207-621-7367 | |
Linda Sue Gallion, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 66 Stone St, Augusta, ME 04330 Phone: 207-626-3455 Fax: 207-626-3612 | |
Chelsea Victoria Short, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 10 Caldwell Rd, Augusta, ME 04330 Phone: 207-616-6849 | |
Sara Mae Mcgrane, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr Unit 63, Augusta, ME 04330 Phone: 207-623-8411 |